{"id":"https://openalex.org/W3083237144","doi":"https://doi.org/10.1158/1538-7445.am2020-3769","title":"Abstract 3769: Combined TRKA and MEK1/2 Inhibition Forestalls the Onset of Acquired Resistance in a New Preclinical Model of NTRK1+ Pancreatic Cancer","display_name":"Abstract 3769: Combined TRKA and MEK1/2 Inhibition Forestalls the Onset of Acquired Resistance in a New Preclinical Model of NTRK1+ Pancreatic Cancer","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083237144","doi":"https://doi.org/10.1158/1538-7445.am2020-3769","mag":"3083237144"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-3769","doi":"https://doi.org/10.1158/1538-7445.am2020-3769","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3769","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008388455","display_name":"Aria Vaishnavi","orcid":"https://orcid.org/0000-0002-7814-3234","observed_orcids":["https://orcid.org/0000-0002-7814-3234"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aria Vaishnavi","raw_affiliation_strings":["University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049404406","display_name":"Michael T. Scherzer","orcid":"https://orcid.org/0000-0001-9092-0529","observed_orcids":["https://orcid.org/0000-0001-9092-0529"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael T. Scherzer","raw_affiliation_strings":["University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080566114","display_name":"Conan Grant Kinsey","orcid":"https://orcid.org/0000-0001-5614-8627","observed_orcids":["https://orcid.org/0000-0001-5614-8627"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Conan Kinsey","raw_affiliation_strings":["University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029563022","display_name":"Ignacio Garrido\u2010Laguna","orcid":"https://orcid.org/0000-0003-2273-9028","observed_orcids":["https://orcid.org/0000-0003-2273-9028"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ignacio Garrido-Laguna","raw_affiliation_strings":["University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003652463","display_name":"Martin McMahon","orcid":"https://orcid.org/0000-0003-2812-1042","observed_orcids":["https://orcid.org/0000-0003-2812-1042"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin McMahon","raw_affiliation_strings":["University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I223532165"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"3769","last_page":"3769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ntrk1-fusion","display_name":"NTRK1 fusion","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/mek1-2-inhibition","display_name":"MEK1/2 inhibition","score":0.9670000076293945},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9390000104904175},{"id":"https://openalex.org/keywords/mapk-pathway-reactivation","display_name":"MAPK pathway reactivation","score":0.8899999856948853},{"id":"https://openalex.org/keywords/entrectinib","display_name":"entrectinib","score":0.7929999828338623},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.47099998593330383},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.996999979019165},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6921945214271545},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6632194519042969},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6300275921821594},{"id":"https://openalex.org/C171034665","wikidata":"https://www.wikidata.org/wiki/Q14897694","display_name":"Tropomyosin receptor kinase A","level":4,"score":0.555572509765625},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5552300810813904},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.529215395450592},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4413040578365326},{"id":"https://openalex.org/C150109051","wikidata":"https://www.wikidata.org/wiki/Q3630494","display_name":"Autophosphorylation","level":4,"score":0.43820852041244507},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43600332736968994},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40650761127471924},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30031877756118774},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2541702389717102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25142738223075867},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.21790143847465515},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.15007749199867249},{"id":"https://openalex.org/C2778423431","wikidata":"https://www.wikidata.org/wiki/Q417782","display_name":"Nerve growth factor","level":3,"score":0.09354057908058167}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-3769","doi":"https://doi.org/10.1158/1538-7445.am2020-3769","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3769","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3047363100","https://openalex.org/W3083345156","https://openalex.org/W2979453163","https://openalex.org/W2560719232","https://openalex.org/W2138277627","https://openalex.org/W2128086717","https://openalex.org/W4282962313","https://openalex.org/W7099907744","https://openalex.org/W4390908283","https://openalex.org/W1803959510"],"abstract_inverted_index":{"Abstract":[0],"NTRK1":[1,122,455],"gene":[2,39,456],"fusions":[3],"encode":[4],"oncoprotein":[5,210],"(TRKA)":[6],"kinases":[7],"that":[8,197,225,307,343],"are":[9,159,203,452],"actionable":[10],"drivers":[11],"of":[12,15,21,31,53,89,101,129,165,208,216,251,263,270,277,284,290,311,320,331,363,376,410,418,437,441,479,487,494,498],"a":[13,19,27,36,110,124,260,267,324,354,357,430,483],"number":[14],"human":[16],"malignancies":[17],"including":[18],"subset":[20],"pancreatic":[22,32,46,116,132,174],"cancers.":[23],"Here,":[24],"we":[25,223,305,345],"describe":[26],"new":[28],"preclinical":[29],"model":[30,75,88,195,335],"cancer":[33,175],"in":[34,42,55,73,131,142,149,173,232,259,333,396,448,482],"which":[35,253],"TPR-NTRK1":[37,54],"fusion":[38],"is":[40,58,123,183],"expressed":[41],"conditionally":[43],"immortalized":[44],"mouse":[45,151],"ductal":[47],"epithelial":[48,133],"(IMPE)":[49],"cells.":[50,134],"Indeed,":[51,274],"expression":[52,279,409],"IMPE":[56,136,155,286,350],"cells":[57,63,137],"sufficient":[59,204],"to":[60,84,114,162,190,205,288,297,301,384],"transform":[61],"these":[62,427],"without":[64],"any":[65],"additional":[66],"engineered":[67],"genetic":[68],"alterations.":[69],"Other":[70],"oncogenes":[71],"tested":[72],"this":[74,86,180,334],"include":[76],"KRAS":[77],"and":[78,109,126,147,185,314,336,473,509],"EGFR,":[79],"but":[80],"neither":[81],"were":[82,394],"unable":[83],"replicate":[85],"one-hit":[87],"transformation.":[90,118],"This":[91,194],"striking":[92],"result":[93,231],"may":[94],"be":[95],"explained":[96],"by":[97,106,415,420,454],"the":[98,150,209,217,242,248,271,282,318,329,338,361,370,374,377,399,402,413,421,434,438,477,495,499],"differential":[99],"levels":[100],"MAPK":[102,219,234,256,315],"pathway":[103,235,340],"activation":[104],"produced":[105],"different":[107],"oncogenes,":[108],"\u201cgoldilocks":[111],"zone\u201d":[112],"required":[113],"drive":[115],"cellular":[117],"These":[119],"data":[120,428],"suggest":[121],"unique":[125],"powerful":[127],"driver":[128],"transformation":[130],"NTRK1-driven":[135],"form":[138],"fast":[139],"growing":[140],"tumors":[141,158,186,287,351],"immunocompromised":[143],"mice":[144,347,397],"both":[145,312,364],"subcutaneously,":[146],"orthotopically":[148],"pancreas.":[152],"Importantly,":[153,387],"TPR-NTRK1-driven":[154,285],"cell":[156],"derived":[157],"exquisitely":[160],"sensitive":[161],"targeted":[163,249,439],"inhibition":[164,250,289,310,443,446],"TRKA":[166,192,291,303,313,322,355,442,472],"kinase":[167,292],"activity.":[168,293],"However,":[169],"as":[170,212,214],"also":[171,405],"observed":[172,224,339,395],"patients":[176,449],"treated":[177,346,368],"with":[178,246,317,352,369],"entrectinib,":[179],"therapeutic":[181,365],"response":[182,283,332],"transient":[184],"eventually":[187],"develop":[188],"resistance":[189,300],"single-agent":[191,302,385],"inhibition.":[193],"revealed":[196,373],"short":[198],"drug":[199,227,239],"treatments":[200,228],"(2":[201],"hours)":[202,230],"block":[206],"autophosphorylation":[207],"target,":[211,243],"well":[213],"blockade":[215],"downstream":[218,233],"signaling":[220,257,316],"pathway.":[221],"Critically,":[222],"long-term":[226],"(24":[229],"reactivation":[236],"despite":[237],"maintained":[238],"activity":[240],"against":[241],"TRKA.":[244],"Consistent":[245],"this,":[247],"TRKA,":[252],"transiently":[254],"blocks":[255],"results":[258],"subsequent":[261],"elevation":[262],"BIM":[264,278,411,419,424],"protein":[265],"expression,":[266],"pro-apoptotic":[268],"member":[269],"BCL2":[272],"family.":[273],"CRISPR/CAS9-mediated":[275],"abrogation":[276],"significantly":[280,381],"diminishes":[281],"In":[294],"an":[295,321],"effort":[296],"delay":[298],"acquired":[299],"inhibitors,":[304],"reasoned":[306],"combined":[308,403],"vertical":[309],"combination":[319,362,372,440],"plus":[323,444],"MEK1/2":[325,358,445,474],"inhibitor":[326,359],"might":[327],"increase":[328],"durability":[330,375],"counteract":[337],"reactivation.":[341],"To":[342],"end,":[344],"bearing":[348],"TPR-NTRK-driven":[349],"either":[353],"inhibitor,":[356],"or":[360,390],"agents.":[366],"Mice":[367],"entrectinib/cobimetinib":[371],"tumor":[378],"regression":[379],"was":[380],"increased":[382],"compared":[383],"entrectinib.":[386],"no":[388],"toxicity":[389],"adverse":[391],"side":[392],"effects":[393],"receiving":[398],"combination.":[400],"Additionally,":[401],"therapies":[404],"induced":[406],"more":[407],"stable":[408],"than":[412],"single-agent,":[414],"delaying":[416],"degradation":[417],"proteasome":[422],"following":[423],"phosphorylation.":[425],"Collectively,":[426],"provide":[429],"compelling":[431],"rationale":[432],"for":[433,502],"clinical":[435],"deployment":[436],"first-line":[447],"whose":[450],"cancers":[451],"driven":[453],"fusions.":[457],"Citation":[458],"Format:":[459],"Aria":[460],"Vaishnavi,":[461],"Michael":[462],"T.":[463],"Scherzer,":[464],"Conan":[465],"Kinsey,":[466],"Ignacio":[467],"Garrido-Laguna,":[468],"Martin":[469],"McMahon.":[470],"Combined":[471],"Inhibition":[475],"Forestalls":[476],"Onset":[478],"Acquired":[480],"Resistance":[481],"New":[484],"Preclinical":[485],"Model":[486],"NTRK1+":[488],"Pancreatic":[489],"Cancer":[490,503,515],"[abstract].":[491],"In:":[492],"Proceedings":[493],"Annual":[496],"Meeting":[497],"American":[500],"Association":[501],"Research":[504],"2020;":[505],"2020":[506],"Apr":[507],"27-28":[508],"Jun":[510],"22-24.":[511],"Philadelphia":[512],"(PA):":[513],"AACR;":[514],"Res":[516],"2020;80(16":[517],"Suppl):Abstract":[518],"nr":[519],"3769.":[520]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-09-11T00:00:00"}